ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Ponatinib, venetoclax and dexamethasone for patients with relapsed or refractory...
Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA
Clinical implications of MRD detection in infants with KMT2A-rearranged ALL Trea...
Dr Janine Stutterheim - Princess Máxima Center, Utrecht, Netherlands
Predictive factors for overall survival in chronic myeloid leukaemia patients: a...
Prof Giuseppe Saglio - A.O. Ordine Mauriziano, Turin, Italy
Cranial radiation mostly eliminated in children with T-ALL and bortezomib potent...
Prof David Teachey - The University of Pennsylvania, Rutledge, USA
Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukae...
Dr William Wierda - University of Texas MD Anderson Cancer Center, Houston, USA
ecancer special issue on immunotherapy
Dr Nicola Fusco and Elham Sajjadi - European Institute of Oncology, Milan, Italy
PARP inhibitors in prostate cancer: A promise delivered
Dr Abhishek Tripathi - Stephenson Cancer Center, Oklahoma City, USA
SIOG 2020 Annual Meeting global message and continuity with SIOG 2021
Prof Holly Holmes and Prof Kwok-Leung Cheung
Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells
Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
Updates in geriatric oncology from SIOG 2020
Dr Siri Rostoft - Oslo University Hospital, Oslo, Norway
SIOG 2020: Prostate cancer and how COVID is impacting the treatment of elderly p...
Prof Nicolas Mottet and Prof Matti Aapro